Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells

International Journal of Antimicrobial Agents

Volumn 32, Issue 1, 2008, Pages 78-83

  Yan, Ying ^a   Silvennoinen Kassinen, Sylvi ^a   Törmäkangas, Liisa ^b   Leinonen, Maija ^b   Saikku, Pekka ^a  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Chlamydia pneumoniae; Cyclooxygenase (COX); Real time PCR

Indexed keywords

4 [5 PHENYL 3 (TRIFLUOROMETHYL) 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BACTERIAL GROWTH; CELL CULTURE; CELL GROWTH; CELL VIABILITY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; HUMANS; INCLUSION BODIES; LYMPHOCYTES; MICROBIAL VIABILITY; PYRAZOLES;

EID: 44949086424     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.02.021     Document Type: Article

References (16)

1. FitzGerald G.A., Smith B., Pedersen A.K., and Brash A.R. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310 (1984) 1065-1068
2. O'Neill G.P., and Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330 (1993) 156-160
3. Burleigh M.E., Babaev V.R., Oates J.A., Harris R.C., Gautam S., Riendeau D., et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105 (2002) 1816-1823
4. McGeer P.L., McGeer E.G., and Yasojima K. Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques. Exp Gerontol 37 (2002) 925-929
5. Pitt B., Pepine C., and Willerson J.T. Cyclooxygenase-2 inhibition and cardiovascular events. Circulation 106 (2002) 167-169
6. Pratico D., Tillmann C., Zhang Z.B., Li H., and FitzGerald G.A. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci USA 98 (2001) 3358-3363
7. Leinonen M., and Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2 (2002) 11-17
8. Ekman M.R., Grayston J.T., Visakorpi R., Kleemola M., Kuo C.C., and Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 17 (1993) 420-425
9. Rupp J., Berger M., Reiling N., Gieffers J., Lindschau C., Haller H., et al. COX-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression. Biochem Biophys Res Commun 320 (2004) 738-744
10. Tiran A., Gruber H.J., Graier W.F., Wagner A.H., Van Leeuwen E.B., and Tiran B. Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells. Arterioscler Thromb Vasc Biol 22 (2002) 1075-1080
11. Dechend R., Maass M., Gieffers J., Dietz R., Scheidereit C., Leutz A., et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100 (1999) 1369-1373
12. Liu W., Dubinett S., Patterson S.L., and Kelly K.A. COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells. Microbes Infect 8 (2006) 478-486
13. Xiang Z., Ho L., Yemul S., Zhao Z., Qing W., Pompl P., et al. Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology. Gene Expr 10 (2002) 271-278
14. Souza R.F., Shewmake K., Beer D.G., Cryer B., and Spechler S.J. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 60 (2000) 5767-5772
15. Gislason G.H., Jacobsen S., Rasmussen J.N., Rasmussen S., Buch P., Friberg J., et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 113 (2006) 2906-2913
16. Tormakangas L., Ketonen J., Leinonen M., Saikku P., and Paakkari I. Increased prostanoid dependency of arterial relaxation in Chlamydia pneumoniae-infected mice. J Med Microbiol 55 (2006) 1017-1021